We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.45%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$417M
AUM Growth
+$5.01M
Cap. Flow
-$3.73M
Cap. Flow %
-0.9%
Top 10 Hldgs %
14.37%
Holding
298
New
40
Increased
72
Reduced
97
Closed
25

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$640K
2
VER
VEREIT, Inc.
VER
+$386K
3
T icon
AT&T
T
+$385K
4
LMT icon
Lockheed Martin
LMT
+$307K
5
FCN icon
FTI Consulting
FCN
+$294K

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Industrials 16.04%
3 Healthcare 12.16%
4 Consumer Discretionary 6.59%
5 Financials 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEY icon
76
KeyCorp
KEY
$25.4B
$1.43M 0.34%
80,522
-3,264
-4% -$55.2K
KLAC icon
77
KLA
KLAC
$278B
$1.42M 0.34%
120,100
+7,620
+7% +$88.1K
VTR icon
78
Ventas
VTR
$46.7B
$1.41M 0.34%
20,589
+8
+0% +$510
MRK icon
79
Merck
MRK
$315B
$1.38M 0.33%
17,294
+1,005
+6% +$77K
T icon
80
AT&T
T
$152B
$1.38M 0.33%
54,566
-16,072
-23% -$385K
LDOS icon
81
Leidos
LDOS
$13.4B
$1.38M 0.33%
17,268
+633
+4% +$46.2K
HBAN icon
82
Huntington Bancshares
HBAN
$37B
$1.37M 0.33%
99,406
-4,201
-4% -$56.4K
LLL
83
DELISTED
L3 Technologies, Inc.
LLL
$1.37M 0.33%
5,602
+141
+3% +$32.9K
EGRX
84
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.34M 0.32%
24,000
MET icon
85
MetLife
MET
$60.5B
$1.33M 0.32%
26,760
+35
+0.1% +$1.65K
NTAP icon
86
NetApp
NTAP
$32.1B
$1.31M 0.31%
21,241
+798
+4% +$53.9K
ORCL icon
87
Oracle
ORCL
$364B
$1.29M 0.31%
22,607
+481
+2% +$26K
NOC icon
88
Northrop Grumman
NOC
$74.1B
$1.28M 0.31%
3,966
-778
-16% -$232K
ECL icon
89
Ecolab
ECL
$76.8B
$1.27M 0.3%
6,414
+401
+7% +$74.6K
NDAQ icon
90
Nasdaq
NDAQ
$51.8B
$1.26M 0.3%
39,372
+1,446
+4% +$44.3K
ROG icon
91
Rogers Corp
ROG
$2.36B
$1.24M 0.3%
7,174
-23
-0.3% -$3.75K
CVS icon
92
CVS Health
CVS
$137B
$1.22M 0.29%
22,459
-4,508
-17% -$243K
MDT icon
93
Medtronic
MDT
$106B
$1.22M 0.29%
12,518
+331
+3% +$30.2K
EXP icon
94
Eagle Materials
EXP
$6.36B
$1.2M 0.29%
12,908
+576
+5% +$50.8K
EVRG icon
95
Evergy
EVRG
$19.7B
$1.19M 0.29%
19,777
+721
+4% +$42.2K
HDS
96
DELISTED
HD Supply Holdings, Inc.
HDS
$1.19M 0.28%
29,450
+983
+3% +$42.2K
TTEK icon
97
Tetra Tech
TTEK
$8.2B
$1.19M 0.28%
75,460
+645
+0.9% +$8.69K
NGVT icon
98
Ingevity
NGVT
$2.66B
$1.18M 0.28%
11,209
-40
-0.4% -$4.02K
VRNS icon
99
Varonis Systems
VRNS
$5.46B
$1.18M 0.28%
56,988
-1,896
-3% -$40.7K
TXT icon
100
Textron
TXT
$15.9B
$1.17M 0.28%
22,087
+1,018
+5% +$51.6K

Similar funds

Stanley-Laman Group's Q2 2019 Portfolio in Review

As of Q2 2019, Stanley-Laman Group held 298 positions worth $417M, up 1.2% from $412M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Stanley-Laman Group's Q2 2019 filing shows 40 new, 72 increased, 97 reduced and 25 closed positions. Its largest new stake was Everpure Inc: 28,689 shares worth $438K. The largest sale was Vanguard S&P 500 ETF, an estimated $640K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q2 2019 buy was Everpure Inc: 28,689 shares worth $438K.
  • Stanley-Laman Group added most to Palo Alto Networks in Q2 2019, an estimated $292K increase.
  • Stanley-Laman Group's biggest Q2 2019 reduction was Vanguard S&P 500 ETF, cutting an estimated $640K.
  • Stanley-Laman Group fully exited FTI Consulting in Q2 2019, selling an estimated $294K.
  • Stanley-Laman Group's ten largest holdings make up 14% of its $417M portfolio in Q2 2019.
  • Stanley-Laman Group opened 40 new positions and closed 25 in Q2 2019.
  • Stanley-Laman Group's portfolio value rose 1.2% quarter-over-quarter to $417M.

Based on Stanley-Laman Group's 13F filing for Q2 2019, filed 1 Aug 2019.